Showing results (141-150 of 276) with videos related to

Sort By:
Pageof 28
Cancers|April 12, 2022
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA GroupChristophe Bonnet, Jehan Dupuis, Hervé Tilly, et al.
Leukemia & Lymphoma|July 16, 2010
Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conferenceMartin Dreyling, Eva Hoster, Silvia Bea, et al.
Neuroscience Applied|July 14, 2025
Colour vision impairments in bipolar disorder: A systematic reviewJason Tran, Arnav Gupta, Nicholas Fabiano, et al.
Biochemical and Biophysical Research Communications|November 21, 2023
Early-life caffeine exposure induces morphological changes and altered physiology in CaenorhabditiselegansLance Kuo-Esser, Ramon Chen, Kylie Lawson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 19, 2016
Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell TransplantationAline Clavert, Zinaida Peric, Eolia Brissot, et al.
Haematologica|March 10, 2022
The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibitionSalomé Decombis, Antonin Papin, Céline Bellanger, et al.
Oncotarget|October 17, 2018
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignanciesPatrice Chevallier, Pierre Peterlin, Alice Garnier, et al.
The Lancet. Haematology|September 3, 2018
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 studyHervé Tilly, Franck Morschhauser, Olivier Casasnovas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignanciesXavier Cahu, Fanny Rialland, Cyrille Touzeau, et al.
Oncoimmunology|June 28, 2021
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell responseDhon Roméo Makanga, Maxime Jullien, Gaëlle David, et al.
Pageof 28